Regarding point #1, TB, Rohan has more than once said he expects very rapid uptake of PYCs treatment, at least for RP11.
Regarding #2, there may be a few elderly patients or those with irreparable eye damage who cannot be helped, but I would expect all others to be on the treatment. Certainly in developed countries. Ditto for PCKD.
I can’t comment on your other 3 points.
All I can say is that I put quite conservative numbers into my spreadsheet and my estimate of value is way, way greater than $1.20. But mine is a future estimate, not “now.” Is the analyst estimate of $1.20 for current valuation?
But I admit I’m no accountant nor financial guru.
So maybe I’m wrong.
One thing I haven’t factored in is “something going wrong” which is a bit nebulous and I don’t know how to account for that, except by introducing “percentages”. But that’s just guesswork IMO.
Cheers
FHC
Regarding point #1, TB, Rohan has more than once said he expects...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.010(10.0%) |
Mkt cap ! $513.2M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 11.0¢ | 10.0¢ | $184.6K | 1.761M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 51807 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 680221 | 5 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| PYC (ASX) Chart |